Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
华尔街最准确的分析师聚焦于3只医疗保健股票，提供高股息收益。
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
在市场动荡和不确定时期，许多投资者会选择高股息股票。这些公司通常具有高自由现金流，并以高股息回报股东。
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.
Benzinga读者可以通过访问分析师股票评级页面，查看他们最喜欢的股票的最新分析师观点。交易者可以浏览Benzinga广泛的分析师评级数据库，包括根据分析师准确性进行排序。
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
以下是医疗保健板块三只高收益股票最准确的分析师的评级。
Amgen Inc. (NASDAQ:AMGN)
AMGEN-T（纳斯达克：AMGN）
- Dividend Yield: 3.67%
- Piper Sandler analyst David Amsellem maintained an Overweight rating and cut the price target from $344 to $310 on Jan. 2. This analyst has an accuracy rate of 66%.
- B of A Securities analyst Tim Anderson reinstated an Underperform rating with a price target of $256 on Dec. 10. This analyst has an accuracy rate of 63%.
- Recent News: On Dec. 10, Amgen increased its first-quarter dividend by 6% from $2.25 to $2.38 per share.
- Benzinga Pro's real-time newsfeed alerted to latest AMGN news.
- 股息收益率：3.67%
- 派杰投资分析师大卫·阿姆斯勒维持了增持评级，并在1月2日将目标价格从344美元下调至310美元。该分析师的准确率为66%。
- 美银证券分析师蒂姆·安德森于12月10日重新给予了表现落后评级，并设定了256美元的目标价格。该分析师的准确率为63%。
- 最新资讯：安进于12月10日将其第一季度的股息从每股2.25美元增加了6%，达到每股2.38美元。
- Benzinga Pro的实时资讯源提醒了最新的安进新闻。
AbbVie Inc. (NYSE:ABBV)
艾伯维公司 (纽交所:ABBV)
- Dividend Yield: 3.66%
- B of A Securities analyst Tim Anderson reinstated a Neutral rating with a price target of $191 on Dec. 10. This analyst has an accuracy rate of 63%.
- Leerink Partners analyst David Risinger upgraded the stock from Market Perform to Outperform with a price target of $206 on Nov. 22. This analyst has an accuracy rate of 75%.
- Recent News: On Dec. 13, AbbVie announced plans to acquire Nimble Therapeutics.
- Benzinga Pro's real-time newsfeed alerted to latest ABBV news
- 股息收益率：3.66%
- 美银证券的分析师TIM安德森在12月10日恢复了中立评级，目标价格为191美元。该分析师的准确率为63%。
- Leerink Partners的分析师大卫·瑞辛格将股票评级从市场表现上调至跑赢市场，目标价格为206美元，日期为11月22日。该分析师的准确率为75%。
- 近期资讯：艾伯维公司于12月13日宣布计划收购Nimble Therapeutics。
- Benzinga Pro的实时资讯源提醒了最新的艾伯维公司新闻。
CVS Health Corporation (NYSE:CVS)
西维斯健康公司（纽约证券交易所股票代码：CVS）
- Dividend Yield: 6.02%
- Deutsche Bank analyst George Hill upgraded the stock from Hold to Buy with a price target of $66 on Dec. 3. This analyst has an accuracy rate of 60%.
- Truist Securities analyst David Macdonald reiterated a Buy rating and lowered the price target from $76 to $67 on Nov. 20. This analyst has an accuracy rate of 63%.
- Recent News: The DOJ recently alleged that CVS violated the Controlled Substances Act by filling unlawful prescriptions for opioid combinations and excessive quantities since 2013.
- Benzinga Pro's charting tool helped identify the trend in CVS stock.
- 股息收益率：6.02%
- 德意志银行的分析师乔治·希尔在12月3日将该股票的评级从持有上调至买入，目标价格为66美元。该分析师的准确率为60%。
- Truist Securities的分析师大卫·麦克唐纳在11月20日重申了买入评级，并将目标价格从76美元下调至67美元。该分析师的准确率为63%。
- 最近的资讯：美国司法部最近指控西维斯健康违反《管控物质法》，自2013年以来非法开具含有阿片类药物的处方并填充过量数量。
- Benzinga Pro的图表工具帮助识别西维斯健康股票的趋势。
Read More:
阅读更多：
- How To Earn $500 A Month From Acuity Brands Stock Ahead Of Q1 Earnings
- 如何在Acuity Brands股票公布第一季度盈利前每月赚取500美元
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
资讯热榜
更新时间